C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 115 filers reported holding C4 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,171,312 | -63.0% | 1,167,372 | -45.3% | 0.00% | -66.7% |
| Q2 2023 | $5,872,892 | +1218342.3% | 2,135,597 | +1290.8% | 0.00% | – |
| Q1 2023 | $482 | -100.0% | 153,556 | -63.9% | 0.00% | -100.0% |
| Q2 2022 | $3,209,000 | -89.3% | 425,647 | -65.6% | 0.00% | -87.5% |
| Q1 2022 | $30,034,000 | +23.8% | 1,238,041 | +64.3% | 0.02% | +33.3% |
| Q4 2021 | $24,259,000 | +88.8% | 753,391 | +162.0% | 0.01% | +50.0% |
| Q3 2021 | $12,849,000 | -11.7% | 287,573 | -25.2% | 0.01% | -11.1% |
| Q2 2021 | $14,551,000 | +119.7% | 384,548 | +114.7% | 0.01% | +80.0% |
| Q1 2021 | $6,624,000 | -63.9% | 179,068 | -67.7% | 0.01% | -61.5% |
| Q4 2020 | $18,373,000 | – | 554,568 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |